March 5, 2026 – As International Women’s Day approaches on March 8, 2026, FACIT is pleased to celebrate the achievements of women-led health and biotech companies that are driving innovative cancer solutions to help patients lead longer and healthier lives.
Tag: leadership
FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program
March 6, 2025 – The Women’s Synergistic Entrepreneurship and Economic Development (WeSEED) program leverages the combined, complementary capital, expertise and resources of OBIO® and FACIT. The resulting synergies provide a continuum of seamless support and lower barriers faced by women STEM leaders in accessing business training, advisory resources, networks and venture funding.
FACIT and OBIO® partner on women-focused seed capital and entrepreneurship program
March 8, 2024 – On International Women’s Day, FACIT and OBIO® are pleased to announce a new partnership in the Ontario life sciences ecosystem, built on their common goal to drive entrepreneurial and commercialization mandates to address the unmet needs and barriers faced by female entrepreneurial leaders in STEM.
Women-led health and biotech companies dominate FACIT’s latest investments
November 20, 2023 – On the globally-recognized Women’s Entrepreneurship Day, FACIT is pleased to announce investments in four breakthrough oncology innovations – all driven by women leaders. November 19th each year is a day to celebrate and showcase women’s contributions to advance communities and to strengthen their empowerment in the entrepreneurial ecosystem to drive economic impact. FACIT’s support of the four ventures, Virano Therapeutics, Hyivy Health, Tenomix Inc., and DTPx Therapeutics are representative of an asset portfolio where over one third are women-led or founded innovations, attracting one third of every dollar invested by FACIT – as much as ten times the average for the venture capital industry.
cTRL Therapeutics announces new Chief Executive Officer to continue advancing its novel immune cell therapy
FACIT appoints seasoned life science leaders to its Board of Directors
November 1, 2023 – FACIT is pleased to welcome two new directors to its Board, Dr. Maura Campbell and Dr. Laszlo Radvanyi. Dedicated to commercializing Ontario intellectual property and impacting patients with cancer, both executives bring with them decades of private and public sector leadership experiences.